Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02362386 · ClinicalTrials.gov registry record
Feasibility of Obtaining ADRCs From Discarded Thermal Burn Eschar Tissue Using Investigational Celution® System
A clinical trial, sponsored by Cytori Therapeutics.
- Completed
- Registry status
- 17
- Enrollment target
NCT02362386: Completed study, sponsored by Cytori Therapeutics.
NCT02362386 is a clinical trial that has completed, run by Cytori Therapeutics. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02362386 has completed, sponsored by Cytori Therapeutics.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The objective of the study is to assess the logistical and biological feasibility of preparing ADRCs from adipose tissue excised during standard-of-care burn wound excision using the Celution® System for autologous, same-day application to the burn wound.
Primary Outcome
Examine various parameters including time to assess how processing of adipose tissue using Celution Device could be integrated into standard-of-care thermal burn wound excision
Interventions
- DEVICE Celution Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-02 |
What the finished NCT02362386 record still lists
NCT02362386 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Celution Device is the first listed.
NCT02362386 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02362386 about?
NCT02362386 is a clinical study titled "Feasibility of Obtaining ADRCs From Discarded Thermal Burn Eschar Tissue Using Investigational Celution® System". The objective of the study is to assess the logistical and biological feasibility of preparing ADRCs from adipose tissue excised during standard-of-care burn wound excision using the Celution® System for autologous, same-day application to the burn wound.
What is the current status of trial NCT02362386?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2015-06. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02362386?
The interventions under investigation include: Celution Device (DEVICE).
Who is sponsoring clinical trial NCT02362386?
This trial is sponsored by Cytori Therapeutics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia